Additional Context: Progress in preventing mother-to-child transmission (MTCT) of HIV in Kenya is at risk of reversal following USAID funding cuts that have disrupted access to certain drugs. Several counties have reported shortages of nevirapine, used as a component of highly active antiretroviral therapy, and early infant diagnostic kits. This threatens hard-won gains made over recent decades: by 2023, Kenya had achieved nearly 90% coverage of HIV prevention services for pregnant women and 84% access to antiretrovirals, resulting in an MTCT rate of just 7–8.6%.

This information was first published in a July 2025 research brief by Physicians for Human Rights entitled "The System is Folding in on Itself: The Impact of U.S. Global Health Funding Cuts in Kenya." Explore the full report here.

Source: Physicians for Human Rights